Windlas Biotech consolidated net profit declines 12.08% in the September 2021 quarter

Sales rise 13.75% to Rs 115.25 crore

Net profit of Windlas Biotech declined 12.08% to Rs 8.30 crore in the quarter ended September 2021 as against Rs 9.44 crore during the previous quarter ended September 2020. Sales rose 13.75% to Rs 115.25 crore in the quarter ended September 2021 as against Rs 101.32 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales115.25101.32 14 OPM %11.4112.18 -PBDT13.9412.65 10 PBT10.869.37 16 NP8.309.44 -12

Powered by Capital Market - Live News